CURIS, INC. Fair Value, Assets, Level 1 to Level 2 Transfers, Amount
CURIS, INC. (CRIS) had Fair Value, Assets, Level 1 to Level 2 Transfers, Amount of $252.22 thousand as of 2015-12-31, per its 10-K filed 2016-02-29.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount · last filed 2016-02-29
- 2015-12-31: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $252.22K.
- 2015-09-30: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $3.22M.
- 2015-06-30: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $500.11K.
| Period end | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount |
|---|---|
| 2015-12-31 | $252.22K 10-K · filed 2016-02-29 |
| 2015-09-30 | $3.22M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $500.11K 10-Q · filed 2015-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |